DrugDashboards

Moderna COVID-19 Vaccine

Moderna COVID-19 Vaccine · CX-046684 25 ug/.25mL · Injection, Suspension · ROVI Pharma Industrial Services S.A.

NDC 50024-0300-01 · 10 SYRINGE, PLASTIC in 1 CARTON / .25 mL in 1 SYRINGE, PLASTIC · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Moderna COVID-19 Vaccine (Injection, Suspension)

LabelerStrengthFirst seenLast seen
ROVI Pharma Industrial Services S.A.CX-046684 25 ug/.25mLJul 15, 2026Sep 3, 2026
Alloga Logstica Espaa S.L.CX-046684 25 ug/.25mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Moderna COVID-19 Vaccine — NDC 50024-0300-01," retrieved September 3, 2026, https://drugdashboards.com/drug/50024030001.

Free to cite with attribution — see how the data is put together.